879609-70-8

Usage

Uses

Used in Pharmaceutical Industry:
4,6-dichloro-N-(2-Methoxyethyl)pyriMidin-2-aMine is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure and potential pharmacological activities make it a valuable component in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical sector, 4,6-dichloro-N-(2-Methoxyethyl)pyriMidin-2-aMine is used as an intermediate in the synthesis of agrochemicals. Its properties contribute to the creation of effective products for agricultural applications.
It is crucial to handle 4,6-dichloro-N-(2-Methoxyethyl)pyriMidin-2-aMine with care due to its potential health and environmental risks if not properly managed and disposed of.

Upstream product

• 3764-01-0 2,4,6-trichloropyrimidine 
• 109-85-3 2-methoxyethylamine 

Relevant academic research and scientific papers

Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists

Transient receptor potential vanilloid 1 (TRPV1) channel antagonists may have clinical utility for the treatment of chronic nociceptive and neuropathic pain. We recently advanced a TRPV1 antagonist, 3 (AMG 517), into clinical trials as a new therapy for t

De novo design of nonpeptidic compounds targeting the interactions between interferon-α and its cognate cell surface receptor

Type 1 interferons (IFN) bind specifically to the corresponding receptor, IFNAR. Agonists and antagonists for IFNAR have potential therapeutic value in the treatment of viral infections and systemic lupus erythematosus, respectively. Specific sequences on

Vanilloid receptor ligands and their use in treatments

Substituted pyridines and pyrimidines and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.